FIELD: molecular genetics. SUBSTANCE: invention represents isolated nucleic acid molecule that is hybridized under rigid conditions or shows 80% level of identity with defined genome site located above the encoding segment of FSHβ gene, and also DNA construction comprising this nucleic acid molecule as a directing sequence for providing the homologous recombination. EFFECT: expanded assortment of genetic therapeutic agents. 18 cl, 12 dwg, 1 tbl
Authors
Dates
2004-05-27—Published
1999-05-05—Filed